Use of recombinant factor VIIa in operation Iraqi freedom and operation enduring freedom: Survey of army surgeons

Ronald J. Kembro, John D. Horton, Michel Wagner

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Military physicians are using recombinant factor VIIa (rFVIIa) in Iraq and Afghanistan to help stop life-threatening hemorrhage in trauma patients. We constructed a questionnaire and surveyed Army general surgeons deployed to Iraq and/or Afghanistan about their predeployment experience, deployment experience, and projected postdeployment practice regarding rFVIIa usage. Most surgeons had rFVIIa available during their deployment (65%). The drug was used with varying frequency and subjective therapeutic effect. A majority of surgeons (79%) were unaware of any guideline or policy governing the use of rFVIIa. Seventy percent of respondents would use the drug in their future practice. Deployed surgeons generally have positive attitudes regarding the use of rFVIIa, but greater guidance and outcome measures are needed.

Original languageEnglish (US)
Pages (from-to)1057-1059
Number of pages3
JournalMilitary medicine
Volume173
Issue number11
DOIs
StatePublished - Nov 2008

Fingerprint

2003-2011 Iraq War
Afghan Campaign 2001-
Afghanistan
Iraq
Therapeutic Uses
Pharmaceutical Preparations
Outcome Assessment (Health Care)
Surveys and Questionnaires
recombinant FVIIa
Surgeons
Guidelines
Hemorrhage
Physicians

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Use of recombinant factor VIIa in operation Iraqi freedom and operation enduring freedom : Survey of army surgeons. / Kembro, Ronald J.; Horton, John D.; Wagner, Michel.

In: Military medicine, Vol. 173, No. 11, 11.2008, p. 1057-1059.

Research output: Contribution to journalReview article

Kembro, Ronald J. ; Horton, John D. ; Wagner, Michel. / Use of recombinant factor VIIa in operation Iraqi freedom and operation enduring freedom : Survey of army surgeons. In: Military medicine. 2008 ; Vol. 173, No. 11. pp. 1057-1059.
@article{37638be20917460e8ad3d947c0c4afe2,
title = "Use of recombinant factor VIIa in operation Iraqi freedom and operation enduring freedom: Survey of army surgeons",
abstract = "Military physicians are using recombinant factor VIIa (rFVIIa) in Iraq and Afghanistan to help stop life-threatening hemorrhage in trauma patients. We constructed a questionnaire and surveyed Army general surgeons deployed to Iraq and/or Afghanistan about their predeployment experience, deployment experience, and projected postdeployment practice regarding rFVIIa usage. Most surgeons had rFVIIa available during their deployment (65{\%}). The drug was used with varying frequency and subjective therapeutic effect. A majority of surgeons (79{\%}) were unaware of any guideline or policy governing the use of rFVIIa. Seventy percent of respondents would use the drug in their future practice. Deployed surgeons generally have positive attitudes regarding the use of rFVIIa, but greater guidance and outcome measures are needed.",
author = "Kembro, {Ronald J.} and Horton, {John D.} and Michel Wagner",
year = "2008",
month = "11",
doi = "10.7205/MILMED.173.11.1057",
language = "English (US)",
volume = "173",
pages = "1057--1059",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "11",

}

TY - JOUR

T1 - Use of recombinant factor VIIa in operation Iraqi freedom and operation enduring freedom

T2 - Survey of army surgeons

AU - Kembro, Ronald J.

AU - Horton, John D.

AU - Wagner, Michel

PY - 2008/11

Y1 - 2008/11

N2 - Military physicians are using recombinant factor VIIa (rFVIIa) in Iraq and Afghanistan to help stop life-threatening hemorrhage in trauma patients. We constructed a questionnaire and surveyed Army general surgeons deployed to Iraq and/or Afghanistan about their predeployment experience, deployment experience, and projected postdeployment practice regarding rFVIIa usage. Most surgeons had rFVIIa available during their deployment (65%). The drug was used with varying frequency and subjective therapeutic effect. A majority of surgeons (79%) were unaware of any guideline or policy governing the use of rFVIIa. Seventy percent of respondents would use the drug in their future practice. Deployed surgeons generally have positive attitudes regarding the use of rFVIIa, but greater guidance and outcome measures are needed.

AB - Military physicians are using recombinant factor VIIa (rFVIIa) in Iraq and Afghanistan to help stop life-threatening hemorrhage in trauma patients. We constructed a questionnaire and surveyed Army general surgeons deployed to Iraq and/or Afghanistan about their predeployment experience, deployment experience, and projected postdeployment practice regarding rFVIIa usage. Most surgeons had rFVIIa available during their deployment (65%). The drug was used with varying frequency and subjective therapeutic effect. A majority of surgeons (79%) were unaware of any guideline or policy governing the use of rFVIIa. Seventy percent of respondents would use the drug in their future practice. Deployed surgeons generally have positive attitudes regarding the use of rFVIIa, but greater guidance and outcome measures are needed.

UR - http://www.scopus.com/inward/record.url?scp=56049119841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56049119841&partnerID=8YFLogxK

U2 - 10.7205/MILMED.173.11.1057

DO - 10.7205/MILMED.173.11.1057

M3 - Review article

C2 - 19055178

AN - SCOPUS:56049119841

VL - 173

SP - 1057

EP - 1059

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 11

ER -